Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:AACTNASDAQ:ARYENASDAQ:CNCKNYSE:FSNB On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAACTAres Acquisition Co. II$11.26+0.3%$11.15$10.58▼$11.26$701.25M-0.01366,279 shs1.57 million shsARYEARYA Sciences Acquisition Corp V$10.36$10.36$9.70▼$10.50$198.81M0.01115,563 shs10,887 shsCNCKCoincheck Group$7.90+7.5%$5.97$4.22▼$14.42$953.30M0.2958,076 shs74,594 shsFSNBFusion Acquisition Corp. II$10.49$10.49$9.52▼$10.75$655.63M0.01N/AN/AThese 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAACTAres Acquisition Co. II0.00%+0.40%+0.90%+2.32%+6.08%ARYEARYA Sciences Acquisition Corp V0.00%0.00%0.00%0.00%0.00%CNCKCoincheck Group0.00%+35.27%+45.49%-17.28%+789,999,900.00%FSNBFusion Acquisition Corp. II0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAACTAres Acquisition Co. IIN/AN/AN/AN/AN/AN/AN/AN/AARYEARYA Sciences Acquisition Corp VN/AN/AN/AN/AN/AN/AN/AN/ACNCKCoincheck Group2.0399 of 5 stars3.50.00.00.03.31.70.0FSNBFusion Acquisition Corp. IIN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAACTAres Acquisition Co. II 0.00N/AN/AN/AARYEARYA Sciences Acquisition Corp V 0.00N/AN/AN/ACNCKCoincheck Group 3.00Buy$10.0026.58% UpsideFSNBFusion Acquisition Corp. II 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest ARYE, CNCK, AACT, and FSNB Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails2/19/2025CNCKCoincheck GroupCantor FitzgeraldSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageOverweight$10.00(Data available from 4/27/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAACTAres Acquisition Co. IIN/AN/A$0.28 per share40.87($0.32) per shareN/AARYEARYA Sciences Acquisition Corp VN/AN/A$0.06 per share163.60($0.25) per shareN/ACNCKCoincheck Group$370.15B0.00N/AN/A$6.01 per share1.31FSNBFusion Acquisition Corp. IIN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAACTAres Acquisition Co. II$16.92MN/A0.00∞N/AN/A-128.65%5.02%5/8/2025 (Estimated)ARYEARYA Sciences Acquisition Corp V$1.22MN/A0.00∞N/AN/A-55.24%1.96%N/ACNCKCoincheck Group-$230KN/A0.00∞N/AN/A-1,943.93%-5.22%N/AFSNBFusion Acquisition Corp. II$16.57MN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAACTAres Acquisition Co. IIN/AN/AN/AN/AN/AARYEARYA Sciences Acquisition Corp VN/AN/AN/AN/AN/ACNCKCoincheck GroupN/AN/AN/AN/AN/AFSNBFusion Acquisition Corp. IIN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAACTAres Acquisition Co. IIN/A2.512.51ARYEARYA Sciences Acquisition Corp VN/A0.140.14CNCKCoincheck GroupN/A1.011.01FSNBFusion Acquisition Corp. IIN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAACTAres Acquisition Co. II72.95%ARYEARYA Sciences Acquisition Corp V75.87%CNCKCoincheck Group33.22%FSNBFusion Acquisition Corp. IIN/AInsider OwnershipCompanyInsider OwnershipAACTAres Acquisition Co. IIN/AARYEARYA Sciences Acquisition Corp VN/ACNCKCoincheck Group65.10%FSNBFusion Acquisition Corp. II73.64%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAACTAres Acquisition Co. IIN/A62.50 millionN/ANot OptionableARYEARYA Sciences Acquisition Corp V2,02119.19 millionN/ANot OptionableCNCKCoincheck GroupN/A129.70 million3.31 millionN/AFSNBFusion Acquisition Corp. II262.50 million3.87 millionNot OptionableARYE, CNCK, AACT, and FSNB HeadlinesRecent News About These CompaniesInflection Point Acquisition Corp. II WtSeptember 28, 2024 | wsj.comFusionIQ Achieves SOC 2 Type II Compliance, Reinforcing Commitment to Data SecuritySeptember 25, 2024 | tmcnet.comFusionIQ reinforces data efforts with SOC 2 Type II ComplianceSeptember 25, 2024 | msn.comImpact Development Group Enters into Term Sheet to Acquire FusionAugust 20, 2024 | msn.comMarines' New Fusion Center: Accelerating Future Warfare CapabilitiesMay 6, 2024 | msn.comMarines new ‘Fusion Center’ aimed transitioning cutting edge tech more smoothlyMay 2, 2024 | breakingdefense.comFusion Pharmaceuticals: Market Perform Rating Amid Acquisition and Promising Prostate Cancer Treatment DataApril 12, 2024 | markets.businessinsider.comAstraZeneca Buys Fusion for Up to $2.4 Bln -- UpdateMarch 19, 2024 | marketwatch.comFusion Pharmaceuticals Is Being Acquired by AstraZeneca in $2.4 Billion Deal. The Stock Is Soaring.March 19, 2024 | msn.comAstraZeneca Buys Fusion for Initial $2 BlnMarch 19, 2024 | msn.comFusion Acquisition to redeem outstanding class A sharesDecember 26, 2023 | msn.comFusion Acquisition Corp. II Announces Redemption of SharesDecember 22, 2023 | markets.businessinsider.comFusion92 Announces Acquisition of TRAK DataNovember 16, 2023 | markets.businessinsider.comDealerOn announces acquisition of fusionZONE Automotive.November 13, 2023 | markets.businessinsider.comFusion Acquisition Corp. II Receives Notice from the NYSE Regarding Immediate Suspension in Trading of Securities and Commencement of Delisting ProceedingsOctober 20, 2023 | finance.yahoo.comNYSE to Commence Delisting Proceedings Against Fusion Acquisition Corp. II (FSNB)October 17, 2023 | finance.yahoo.comHyperloopTT announces plans to go public — againAugust 30, 2023 | bizjournals.comFusion Acquisition announces letter of intent to merge with Hyperloop Transportation TechnologiesAugust 30, 2023 | seekingalpha.comHyperloop Transportation Technologies and Fusion Acquisition Corp. II Announce Letter of Intent for a Business CombinationAugust 30, 2023 | finance.yahoo.comFusion Acquisition Corp. II Cl AAugust 22, 2023 | wsj.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeARYE, CNCK, AACT, and FSNB Company DescriptionsAres Acquisition Co. II NYSE:AACT$11.26 +0.04 (+0.31%) Closing price 04/25/2025 03:55 PM EasternExtended Trading$11.25 -0.01 (-0.04%) As of 04/25/2025 07:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Ares Acquisition Corp. II is a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on March 15, 2021 and is headquartered in New York, NY.ARYA Sciences Acquisition Corp V NASDAQ:ARYEARYA Sciences Acquisition Corp V does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in the healthcare or healthcare-related industries. The company was incorporated in 2021 and is based in New York, New York.Coincheck Group NASDAQ:CNCK$7.90 +0.55 (+7.48%) As of 04/25/2025 04:00 PM EasternCoincheck Group NV. is a Dutch public limited liability company and a holding company of Coincheck, Inc. which operates one of the largest multi-cryptocurrency marketplaces and crypto asset exchanges in Japan and is regulated by the Financial Services Agency of Japan. The company was founded on February 18, 2022 and is headquartered in Amsterdam, Netherland.Fusion Acquisition Corp. II NYSE:FSNB$10.49 0.00 (0.00%) As of 04/25/2025Fusion Acquisition Corp. II does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company intends to acquire businesses in the wealth, financial advice, investment, and asset management sectors, as well as FinTech sector. Fusion Acquisition Corp. II was incorporated in 2021 and is based in New York, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 04/21 - 04/25 Bears Can Reap Big Benefits With These 3 Short ETF Bets If You Wanted To Buy AbbVie and Didn’t, There’s Still Time To Buy 3 Stocks To Watch For When Tariffs Subside 3 Boring Stocks Outperforming the Market This Year Short Sellers Gave Up on These 3 Names Recently Churchill Downs Stock: Could Tariff Fears Dampen Derby Gains? Markets Think Robinhood Earnings Could Send the Stock Up Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
